Bryan Goodwin
Impact in
- Pharmacology top 0.01%
- Pharmacogenetics and Drug Metabolism
- Oncology top 0.1%
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 31
- Drug Transport and Resistance Mechanisms 31
- Pharmacology 31
- Pharmacogenetics and Drug Metabolism 31
- Co-authors
- Steven A. Kliewer (21 shared papers)Timothy M. Willson (14 shared papers)Stacey A. Jones (9 shared papers)Linda B. Moore (7 shared papers)Christopher Liddle (13 shared papers)Jon L. Collins (7 shared papers)David D. McKee (2 shared papers)Guizhen Luo (4 shared papers)
- Journals
- Molecular Pharmacology (6 papers)Journal of Biological Chemistry (6 papers)Molecular Endocrinology (4 papers)Proceedings of the National Academy of Sciences (3 papers)Cell Metabolism (3 papers)
- Partner nations
- United StatesAustraliaNetherlands
In The Last Decade
Bryan Goodwin
69 papers receiving 13.8k citations
Bryan Goodwin's Hit Papers
Peers
Comparison fields: 5 of 135
- Pharmacology 4.7k
- Oncology 6.0k
- Endocrinology, Diabetes and Metabolism 2.2k
- Hepatology 783
- Biochemistry 622
Countries citing papers authored by Bryan Goodwin
This map shows the geographic impact of Bryan Goodwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan Goodwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan Goodwin more than expected).
Fields of papers citing papers by Bryan Goodwin
This network shows the impact of papers produced by Bryan Goodwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan Goodwin. The network helps show where Bryan Goodwin may publish in the future.
Co-authors
The 25 scholars most cited alongside Bryan Goodwin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Regulatory Cascade of the Nuclear Receptors FXR, SHP-1, and LRH-1 Represses Bile Acid Biosynthesis Hit paper breakdown → | 2000 | 1606 |
| 2 | Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis Hit paper breakdown → | 2005 | 1482 |
| 3 | The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity Hit paper breakdown → | 2001 | 1117 |
| 4 | The Nuclear Pregnane X Receptor: A Key Regulator of Xenobiotic Metabolism Hit paper breakdown → | 2002 | 740 |
| 5 | Regulation of Multidrug Resistance-associated Protein 2 (ABCC2) by the Nuclear Receptors Pregnane X Receptor, Farnesoid X-activated Receptor, and Constitutive Androstane Receptor Hit paper breakdown → | 2002 | 723 |
| 6 | St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor Hit paper breakdown → | 2000 | 709 |
| 7 | Orphan Nuclear Receptors Constitutive Androstane Receptor and Pregnane X Receptor Share Xenobiotic and Steroid Ligands Hit paper breakdown → | 2000 | 685 |
| 8 | Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis Hit paper breakdown → | 2003 | 562 |
| 9 | The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation ofCYP3A4by Rifampicin through a Distal Enhancer Module Hit paper breakdown → | 1999 | 559 |
| 10 | Nuclear Pregnane X Receptor and Constitutive Androstane Receptor Regulate Overlapping but Distinct Sets of Genes Involved in Xenobiotic Detoxification Hit paper breakdown → | 2002 | 554 |
| 11 | A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects Hit paper breakdown → | 2016 | 413 |
| 12 | 2003 | 353 | |
| 13 | 2003 | 318 | |
| 14 | 2001 | 304 | |
| 15 | 2002 | 269 | |
| 16 | 2015 | 247 | |
| 17 | 2005 | 245 | |
| 18 | 2002 | 213 | |
| 19 | 2004 | 186 | |
| 20 | 2005 | 163 |
About Bryan Goodwin
Bryan Goodwin is a scholar working on Oncology, Pharmacology, Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery, having authored 69 papers that have together received 14.1k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (31 papers), Pharmacogenetics and Drug Metabolism (31 papers), Cholesterol and Lipid Metabolism (13 papers), Hormonal Regulation and Hypertension (13 papers), Estrogen and related hormone effects (13 papers), Liver Disease Diagnosis and Treatment (8 papers), Epigenetics and DNA Methylation (6 papers) and Lipid metabolism and biosynthesis (5 papers). The work is most often cited by research in Pharmacology (4.7k citations), Oncology (6.0k citations), Endocrinology, Diabetes and Metabolism (2.2k citations), Hepatology (783 citations) and Biochemistry (622 citations). Bryan Goodwin has collaborated with scholars based in United States, Australia and Netherlands. Frequent co-authors include Steven A. Kliewer, Timothy M. Willson, Stacey A. Jones, Linda B. Moore, Christopher Liddle, Jon L. Collins, David D. McKee, Guizhen Luo, Jodi M. Maglich and Michael A. Watson. Their work appears in journals such as Molecular Pharmacology, Journal of Biological Chemistry, Molecular Endocrinology, Proceedings of the National Academy of Sciences and Cell Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.